HELSINKI (Reuters) - Danish biotech firm Genmab's
The fund had held more than 5 percent of Genmab shares earlier this month, according to a company fact sheet.
Johnson & Johnson
Genmab shares were trading at 194.9 crowns by 7:35 a.m. ET.
The company reported an operating profit of 29 million crowns in the three months through March compared with a 44 million loss in the same quarter last year. But it expects an operating loss of 40-90 million crowns in 2013.
(Reporting by Helsinki newsroom; editing by Tom Pfeiffer)
(c) Copyright Thomson Reuters 2013. Check for restrictions at: http://about.reuters.com/fulllegal.asp